相关实验视频

Updated: Jul 23, 2025

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

基于异构醇的新型FXa抑制剂:分子建模,体设计和对接模拟

Marcin Gackowski¹, Burhanuddin Madriwala², Renata Studzińska³

¹Department of Toxicology and Bromatology, Faculty of Pharmacy, L. Rydygier Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Torun, A. Jurasza 2 Street, 85089 Bydgoszcz, Poland.

Molecules (Basel, Switzerland)

|July 14, 2023

概括

研究人员设计了新型异醇衍生物作为人类激活的凝血因子X (FXa) 的潜在抑制剂,用于抗凝血药物治疗. 计算机建模确定了有潜力开发新型抗凝固药物的有希望的化合物.

科学领域:

药用化学医学化学
计算化学计算化学
药理学药理学是指药理学的学科.

背景情况:

直接口服抗凝剂对于血栓栓塞性疾病至关重要,但具有局限性.
寻求新型FXa抑制剂来克服现有的药物限制.
石醇是一种石酸衍生物,表现出有前途的抗凝剂活性.

研究的目的:

设计新型的氧化异骨醇衍生物作为潜在的FXa抑制剂.
使用in silico方法,包括QSAR和分子对接,以识别有效的化合物.
探索基于异骨醇的结构,以开发新的抗凝剂.

主要方法:

在石化设计的异维醇衍生物.
使用人工神经网络 (ANN) 模型进行定量结构-活动关系 (QSAR) 分析.
分子对接模拟以预测与FXa.Xa的结合亲和力.

主要成果:

一个包含拓和几何特征的ANN模型显示,与FXa抑制活性有显著的相关性.
分子对接确定了六种有前途的异醇类化合物.
最佳的衍生品包括带有或替代剂的异环环,芳香五环.

结论:

这项研究成功地确定了具有作为FXa抑制剂潜力的新型异醇衍生物.
在的方法为设计新的抗凝固剂提供了有价值的框架.
这些发现为开发基于异维醇的更安全,更有效的抗凝剂提供了洞察力.

关键词:

这是一种FXa抑制剂.在QSAR中使用QSAR.人工神经网络的人工神经网络这是一个对接模拟模拟.类似异维醇的FXa抑制剂分子建模分子建模血栓形成的原因是血栓形成.

更多相关视频

Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia

Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia

Published on: April 7, 2023

Application of I TASSER, trRosetta, UCSF Chimera, HADDOCK server, and HEX loria for De Novo and In Silico Design of Proteins

Application of I TASSER, trRosetta, UCSF Chimera, HADDOCK server, and HEX loria for De Novo and In Silico Design of Proteins

Published on: July 8, 2025

相关概念视频

Structure-Activity Relationships and Drug Design

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...

Molecular Models

Molecular Models

Physical models representing molecular architectures of chemical compounds play essential roles in understanding chemistry. The use of molecular models makes it easier to visualize the structures and shapes of atoms and molecules.